Causes of Elevated Maternal Serum Alpha-Fetoprotein (MSAFP)
Fetal Structural Abnormalities
- Open Neural Tube Defects (ONTDs) can be detected by elevated MSAFP levels in 75-90% of cases and 95% of anencephaly cases, according to the American College of Medical Genetics and Genomics 1
- Ventral Wall Defects, including Gastroschisis, are associated with very elevated MSAFP levels, as reported by the American College of Medical Genetics and Genomics 2, 3
- Omphalocele can have normal to elevated MSAFP levels, as noted by the American College of Medical Genetics and Genomics 2, 3
- Cystic Hygroma is associated with elevated MSAFP, as reported by the American Society of Human Genetics 4, 2
Other Fetal Conditions
- Congenital Nephrosis is associated with very elevated MSAFP levels, according to the American College of Medical Genetics and Genomics 2, 3
- Fetal Demise can cause elevated MSAFP, as noted by the American College of Medical Genetics and Genomics 2, 3
Maternal Factors
- Lower maternal weight is associated with higher MSAFP levels, and values should be adjusted for maternal weight, as reported by the American Society of Human Genetics 5, 6
- MSAFP levels are typically higher in Black/African American women compared to Caucasian women, according to the American Society of Human Genetics 5, 6
- Insulin-Dependent Diabetes affects MSAFP distribution and interpretation, as noted by the American Society of Human Genetics 5, 6
Clinical Significance and Management
- MSAFP screening is optimally performed between 16-18 weeks gestation, and cut-off levels for ONTD screening are typically 2.0-2.5 MoM in singleton pregnancies and 4.0-5.0 MoM in twin pregnancies, as recommended by the American College of Medical Genetics and Genomics 1
- When MSAFP is elevated, follow-up should include genetic counseling, targeted ultrasound examination, and possibly amniocentesis, according to the American College of Medical Genetics and Genomics 1
Common Pitfalls in Interpretation
- Gestational Age Errors require reinterpretation of MSAFP results if there is a discrepancy in gestational age of 2 or more weeks after ultrasound examination, as noted by the American College of Medical Genetics and Genomics 1
- Sample Timing is critical, and samples drawn at less than 15 weeks gestation may give inaccurate results, according to the American College of Medical Genetics and Genomics 1
- Inadequate Clinical Information, including maternal weight, race, diabetes status, and gestational age, can affect proper interpretation of MSAFP results, as reported by the American Society of Human Genetics 5, 7
Management of Positive Maternal Serum AFP Screen
Initial Assessment Algorithm
- For a minimally elevated AFP, a second serum sample is recommended before proceeding to invasive testing, but if the AFP is very elevated or the pregnancy is relatively advanced, proceed directly to ultrasound evaluation without repeat testing, as suggested by the American College of Medical Genetics 8
- Genetic counseling should be provided at each step of the evaluation process, according to the American College of Medical Genetics 8, 9
Systematic Follow-Up Protocol
- Level I ultrasound should be used to exclude incorrect gestational age, as recommended by the American College of Radiology 9
- If elevated AFP persists after excluding other causes, prompt consultation or referral to a center with level II ultrasound capability is recommended, as suggested by the American College of Obstetricians and Gynecologists 8, 9
Critical Considerations
- Insulin-dependent diabetes is associated with lower AFP levels on average, according to the American Diabetes Association 8
- The optimal screening window is 16-18 weeks gestation, and testing outside this window increases false-negative rates, as recommended by the American College of Obstetricians and Gynecologists 8
Documentation Requirements
- Both the initial and repeat AFP values should be documented in mass units and multiples of the median (MoM), as recommended by the American College of Medical Genetics 8
- Risk assessment information specific to the patient's test result should be provided, not just the MoM value, according to the American College of Medical Genetics 8, 9
Management of Elevated Maternal Serum Alpha-Fetoprotein
Diagnostic Approach
- The American College of Medical Genetics recommends considering amniocentesis if ultrasound is inconclusive or shows concerning findings, to measure amniotic fluid AFP and acetylcholinesterase (AChE), with amniotic fluid AFP ≥2.0 MoM considered abnormal 10, 11
- Combined AFP and AChE testing achieves a 97% detection rate for open spina bifida with only a 0.1% false-positive rate 12, 13, 14